SCHEMBL7355394

SCHEMBL7355394

[CH]1CCOC1c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.44
CYP2C19 P33261 6/20 0.44
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SLC6A2 P23975 2/20 0.37
ADRA1A P35348 2/20 0.37
SLC6A3 Q01959 2/20 0.37
HTR2B P41595 1/20 0.37
HTR1A P08908 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.34
MAOA P21397 7/20 0.33
MAOB P27338 7/20 0.33
KDM1A O60341 5/20 0.33
CYP2B6 P20813 3/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 2/20 0.33
TAAR1 Q96RJ0 2/20 0.33
LMNA P02545 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16969461 0.87 TSHR (0.41) TSHRCYP2C19MEN1KMT2ASLC6A2
SCHEMBL27720544 0.78 CYP2C19 (0.59) TSHRCYP2C19MEN1KMT2ASLC6A2
SCHEMBL9217960 0.77 CYP2A6 (0.44) CYP2C19MEN1KMT2ASMN1; SMN2CYP1A2
SCHEMBL15517256 0.73 HTR1A (0.51) TSHRHTR2BHTR1AKDM1ALMNA
SCHEMBL15516824 0.70 TSHR (0.33) TSHR
SCHEMBL4612040 0.67 TSHR (0.39) TSHRCYP2C19MEN1KMT2ASLC6A2
SCHEMBL29626010 0.67 TSHR (0.39) TSHRCYP2C19MEN1KMT2ASLC6A2
SCHEMBL15516784 0.66
SCHEMBL366283 0.65 CYP2C19 (0.62) TSHRCYP2C19MEN1KMT2ASLC6A2
Fluoride SCHEMBL28066844 0.65 TSHR (0.94) TSHRCYP2C19MEN1KMT2ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5672615-A MATRIX-DEGRADING METALLOPROTEINASE INHIBITORS NOVARTIS CORPORATION (US) 1997-09-30 US disclosed
US-5646167-A ADMINISTERED AS METALLOPROTEINASE INHIBITOR, ANTITUMOR OR ANTICARCINOGENIC AGENT CIBA-GEIGY CORPORATION (US) 1997-07-08 US disclosed
WO-1996040101-A1 CERTAIN ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACIDS FOR THE TREATMENT OF CERTAIN TUMORS NOVARTIS AG (CH) 1996-12-19 WO disclosed
US-5552419-A METALLOPROTEINASE INHIBITORS CIBA-GEIGY CORPORATION (US) 1996-09-03 US disclosed